Condition

Tobacco Smoking

ClinicalTrials.gov condition label

Clinical trials18
Recruiting1
Common interventions25
Lead sponsors shown15

Clinical trials

18 shown
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesNCT03495024 · 2019-01-01
RECRUITING
Scaling Up Community-based Noncommunicable Disease Research Into Practice in Pokhara Metropolitan City of NepalNCT06740708 · 2025-04-28
ACTIVE_NOT_RECRUITING
E-cigarette Harm Reduction Among PLWHA in South AfricaNCT06169813 · 2025-04-15
COMPLETED
Tobacco Cessation at FDNYNCT05997225 · 2024-05-31
COMPLETED
Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)NCT05295953 · 2022-04-01
COMPLETED
COPD E-cigarette Topography TrainingNCT05510154 · 2022-03-01
COMPLETED
Computer Delivered and Community Health Worker Supported Smoking Cessation InterventionNCT04566159 · 2021-01-11
COMPLETED
Acute Effects of TCIG vs ECIG in PLWHNCT04568395 · 2020-10-01
COMPLETED
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive TreatmentNCT03612804 · 2019-05-10
COMPLETED
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)NCT03873337 · 2019-04-22
COMPLETED
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former SmokersNCT03347838 · 2019-01-30
ACTIVE_NOT_RECRUITING
Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.NCT04594109 · 2017-06-30
COMPLETED
Financial Incentives to Reduce Pediatric Tobacco Smoke ExposuresNCT03099811 · 2017-06-01
COMPLETED
A Study of Tobacco Smoke and Children With Respiratory IllnessesNCT03062709 · 2017-03-12
COMPLETED
E-cigarettes to Promote Smoking Reduction Among Individuals With SchizophreniaNCT02918630 · 2016-10-01
COMPLETED
Cardiovascular Risk Factors And Intensive Dietary CounsellingNCT02173600 · 2014-05-01
UNKNOWN
Decision Support for Smoking Cessation in Young Adults With Severe Mental IllnessNCT01779440 · 2013-01-01
COMPLETED
Study of Bronchial Inflammation in Adolescent Smokers With and Without ObesityNCT00942019 · 2008-10-01
COMPLETED

Common interventions

Nicotine PatchDRUG2Breathe Easy Coalition written materialsBEHAVIORAL1Brief adviceBEHAVIORAL1CBI-CHWBEHAVIORAL1CounselingBEHAVIORAL1E-cigaretteDRUG1E-Cigarette (EC)OTHER1ECIGOTHER1Electronic Decision Support SystemBEHAVIORAL1Group-level Intensive dietary CounsellingBEHAVIORAL1Incentive planBEHAVIORAL1Individual-level Intensive Dietary CounsellingBEHAVIORAL1Maine Tobacco HelplineBEHAVIORAL1Nicotine Replacement Therapy (NRT)OTHER1NivolumabDRUG1opt in enrollment, non-tailored counseling, varenicline started prior to target quit dateOTHER1opt out enrollment, tailored counseling, varenicline started prior to target quit dateOTHER1Persistence Targeted Smoking Cessation in SMI (PTSC-S)BEHAVIORAL1Proactive Telephone Counseling from VA QuitlineBEHAVIORAL1SCALE-NCDBEHAVIORAL1sham controlOTHER1Sham TMSDEVICE1Single TrainingBEHAVIORAL1Smoking cessationBEHAVIORAL1Standard CareOTHER1

Leading sponsors

Johns Hopkins University2Albert Einstein College of Medicine1Andalusian Regional Ministry of Health1Colorado State University1Corporal Michael J. Crescenz VA Medical Center1Dartmouth-Hitchcock Medical Center1Gopalkumar Rakesh1Johann Wolfgang Goethe University Hospital1Johns Hopkins Bloomberg School of Public Health1MaineHealth1NYU Langone Health1Rutgers, The State University of New Jersey1The University of Texas Health Science Center, Houston1University of California, Los Angeles1University of Colorado, Denver1

Trial status mix

COMPLETED14
ACTIVE_NOT_RECRUITING2
RECRUITING1
UNKNOWN1

Phase mix

NA13
PHASE42
PHASE11
PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.